Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine for post-stroke dysphagia
IRCT20210216050383N1Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pyridostigmine in dysphagia following cerebral infarction, sponsored by Iran University of Medical Sciences. Started Feb 2021; status: completed.
02
Drugs
pyridostigmine
03
Conditions
dysphagia following cerebral infarction
Beyond the preview
Go deeper on IRCT20210216050383N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210216050383N1.